ADI1 and hepatocellular carcinoma: Yet, neither the nuclear ADI1 in the cancerous parts nor the nuclear ADI1 in the non-cancerous parts was associated with postoperative HCC recurrence (recurrence-free survivals, p = 0.072 and 0.664, respectively).